Hypogonadism Clinical Trial
Official title:
Psychological Outcomes in Isolated GNRH Deficiency
Background:
- Isolated (or Congenital) GnRH Deficiency (IGD) is a rare disease. People who have this go
through puberty late. Some never reach puberty or don t complete it without treatment. They
also may have an impaired sense of smell or other health problems. Research shows that
disorders like this can have a negative effect on a person s psychological profile.
Objective:
- To understand the psychological outcomes in people with IGD. These can include depression,
anxiety, poor health, and poor social function.
Eligibility:
- Adults age 18 and over with IGD. They must be currently on a full dose of hormone
replacement therapy for at least 3 months.
- Healthy adult volunteers.
Design:
- Participants will get a username and password. This will give them access to questions
online. They can do this from any computer connected to the Internet.
- Participants will log in and complete the questionnaires. There are 5 total, but they
will appear as 1 continuous set of questions. Answering them takes about 1 hour or less.
- The first set is about the participant s disorder. The rest ask about depression,
anxiety, global health, and social function.
- All answers will be used for research and to better understand reproductive disorders.
Only researchers from the NIH Unit on Genetics of Puberty and Reproduction and from this
study will know which answers belong to which participant.
Isolated GnRH Deficiency (IGD) is a rare disorder characterized by decreased secretion of
GnRH, resulting in impaired gonadotropin secretion and subsequent impaired sex-steroid
production. Patients with this rare clinical syndrome present with absent, delayed, or
stalled pubertal development by eighteen years of age. In addition, non-reproductive
phenotypes of this spectrum have been identified in some individuals, including anosmia,
auditory and ocular defects, and skeletal, neurological, and renal anomalies.
Due to the complex heterogeneity among affected individuals and the rarity of the disease
itself, the phenotypic spectrum has not been fully investigated. The relationship between
psychological disorders and IGD remains largely unexplored as a phenotypic association,
despite evidence that disorders of puberty and reproduction can have a negative impact on the
psychological profile.
This study aims to conduct a preliminary investigation into the association between
psychological symptoms and IGD. We plan to recruit adult patients with a diagnosis of IGD to
complete online assessments that measure psychological health outcomes from the patient
perspective in order to gauge the prevalence of negative emotional states among affected
individuals, compared to healthy controls. This will determine whether further studies are
necessary to investigate psychiatric disease as part of the phenotypic spectrum of the
disorder, and will improve our understanding of this complex disorder as a whole. Greater
knowledge of the psychological impact of IGD may impact the current standards of evaluation
and treatment of patients with delayed pubertal maturation.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03126656 -
Effects of Testosterone on Myocardial Repolarization
|
Phase 4 | |
Terminated |
NCT02419105 -
Effects of Transdermal Testosterone and/or Monthly Vitamin D on Fall Risk in Pre--frail Hypogonadal Seniors
|
Phase 3 | |
Withdrawn |
NCT02137265 -
Assessing the Efficacy of Clomiphene Citrate in Patients With Azoospermia and Hypoandrogenism
|
N/A | |
Completed |
NCT02222558 -
Oral Testosterone for the Treatment of Hypogonadism in Males
|
Phase 2 | |
Completed |
NCT02233751 -
Pharmacokinetic Study of Subcutaneous Testosterone Enanthate
|
Phase 1 | |
Completed |
NCT01887418 -
Pharmacokinetic Study of Testosterone Enanthate
|
Phase 1/Phase 2 | |
Terminated |
NCT01092858 -
NEBIDO in Symptomatic Late Onset Hypogonadism (SLOH)
|
Phase 4 | |
Completed |
NCT00624624 -
Follow-up of Serum Androgen Profile After Bariatric Surgery in Men With Obesity Related Hypogonadotropic Hypogonadism
|
N/A | |
Completed |
NCT00752869 -
Efficacy Study for Use of Dutasteride (Avodart) With Testosterone Replacement
|
Phase 4 | |
Completed |
NCT00613288 -
Testosterone and Lipolysis, Insulin Sensitivity and Protein Metabolism
|
N/A | |
Completed |
NCT00119483 -
Older Men and Testosterone
|
N/A | |
Completed |
NCT00838838 -
Efficacy of Nebido on Bone Mineral Density (BMD) in Hypogonadal Paraplegic Patients With Confirmed Osteoporosis
|
N/A | |
Completed |
NCT00004438 -
Leuprolide in Treating Adults With Hypogonadotropism
|
N/A | |
Withdrawn |
NCT00398034 -
Analgesic Efficacy of Testosterone Replacement in Hypogonadal Opioid-treated Chronic Pain Patients: A Pilot Study.
|
Phase 2 | |
Completed |
NCT02921386 -
The Effect of Various Amounts of Fat on PK of Oral Testosterone Undecanoate
|
Phase 2 | |
Completed |
NCT02937740 -
Open-Label Study, Evaluating Patient Satisfaction and Symptom Improvement When Treating Male Hypogonadism With Natestoâ„¢
|
Phase 4 | |
Completed |
NCT01717768 -
Oral Testosterone for the Treatment of Hypogonadism
|
Phase 2 | |
Terminated |
NCT01460654 -
Testosterone and Alendronate in Hypogonadal Men
|
Phase 2 | |
Completed |
NCT00998933 -
Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure
|
Phase 1 | |
Terminated |
NCT00743327 -
Androgen Deprivation Therapy Study
|
N/A |